Good Results with Individually Adapted Long-Term Immunosuppression Following Alemtuzumab Versus ATG Induction Therapy in Combined Kidney-Pancreas Transplantation: A Single-Center Report

Claudia Bösmüller; Franka Messner; Christian Margreiter; Robert Öllinger; Manuel Maglione; Rupert Oberhuber; Stefan Scheidl; Hannes Neuwirt; Dietmar Öfner; Raimund Margreiter; Stefan Schneeberger

doi:10.12659/AOT.911712

25 January 2019 : Letter/Correspondence

Good Results with Individually Adapted Long-Term Immunosuppression Following Alemtuzumab Versus ATG Induction Therapy in Combined Kidney-Pancreas Transplantation: A Single-Center Report

Claudia Bösmüller^1ABCDEF*, Franka Messner^1BC, Christian Margreiter^1D, Robert Öllinger^2D, Manuel Maglione^1D, Rupert Oberhuber^1D, Stefan Scheidl^1D, Hannes Neuwirt^3D, Dietmar Öfner^1E, Raimund Margreiter^1AE, Stefan Schneeberger^1DE

DOI: 10.12659/AOT.911712

Ann Transplant 2019; 24:52-56

Authors information Article notes Copyright and License information